Related Experiment Videos
Methylphenidate: its pharmacology and uses.
1Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clinic Proceedings
|July 25, 2000
Summary
Methylphenidate, a central nervous system stimulant, is approved for ADHD and narcolepsy. It shows efficacy in treating depression, pain, and other conditions, with a unique mechanism of action.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Medicine
Background:
- Methylphenidate is a widely prescribed central nervous system stimulant in the U.S.
- Its mechanism of action differs from amphetamines.
- It is approved for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy.
Purpose of the Study:
- To review the mechanism of action of methylphenidate.
- To summarize its efficacy in various clinical conditions.
- To provide an overview of current understanding and applications.
Main Methods:
- Review of placebo-controlled trials.
- Analysis of clinical data from various patient populations.
- Synthesis of existing literature on methylphenidate's effects.
Main Results:
- Methylphenidate's efficacy is documented as an adjunctive treatment for depression and pain.
- Its use is advocated in patients with traumatic brain injury, stroke, HIV, and cancer.
- The drug's distinct mechanism of action is highlighted.
Conclusions:
- Methylphenidate possesses a unique mechanism of action.
- It demonstrates efficacy beyond its approved indications, including adjunctive roles in depression and pain management.
- Further understanding of its broad clinical utility is supported by current evidence.